TipRanks
Medtronic (IT:1MDT)
:1MDT
Italy Market
1MDT
Medtronic
RESEARCH TOOLSreports

Medtronic (1MDT) Stock Forecast & Price Target

3 Followers
See the Price Targets and Ratings of:

1MDT Analyst Ratings

Moderate Buy
20Ratings
Moderate Buy
12 Buy
8 Hold
0 Sell
Based on 20 analysts giving stock ratings to
Medtronic
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

1MDT Stock 12 Month Forecast

Average Price Target

€91.23
▲(15.86% Upside)
Based on 20 Wall Street analysts offering 12 month price targets for Medtronic in the last 3 months. The average price target is €91.23 with a high forecast of €104.10 and a low forecast of €74.99. The average price target represents a 15.86% change from the last price of €78.74.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"61":"€61","72":"€72","83":"€83","94":"€94","105":"€105"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":104.0995823,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€104.10</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":91.22984331176474,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€91.23</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":74.98698725,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€74.99</span>\n  </div></div>","useHTML":true}}],"tickPositions":[61,72,83,94,105],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,78.845,80.78766017692307,82.73032035384615,84.67298053076922,86.61564070769231,88.55830088461538,90.50096106153846,92.44362123846153,94.38628141538462,96.32894159230769,98.27160176923077,100.21426194615384,102.15692212307692,{"y":104.0995823,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,78.845,79.79768025475113,80.75036050950227,81.7030407642534,82.65572101900453,83.60840127375567,84.5610815285068,85.51376178325793,86.46644203800906,87.4191222927602,88.37180254751134,89.32448280226247,90.27716305701361,{"y":91.22984331176474,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,78.845,78.54822978846154,78.25145957692308,77.95468936538461,77.65791915384615,77.3611489423077,77.06437873076923,76.76760851923076,76.4708383076923,76.17406809615385,75.87729788461539,75.58052767307692,75.28375746153846,{"y":74.98698725,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":76.69,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.357,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.309,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":86.774,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.859,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":84.92,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.712,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.073,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":67.173,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":62.965,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.965,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.873,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.845,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€104.10Average Price Target€91.23Lowest Price Target€74.99
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen Analyst forecast on IT:1MDT
Josh Jennings
TD Cowen
TD Cowen
€97.04
Buy
23.24%
Upside
Reiterated
09/30/26
Analysts Offer Insights on Healthcare Companies: Medtronic (NYSE: MDT) and Conavi Medical (Other OTC: CNVIF)
Piper Sandler Analyst forecast on IT:1MDT
Matthew O'Brien
Piper Sandler
Piper Sandler
€74.99
Hold
-4.77%
Downside
Reiterated
09/28/26
Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (NASDAQ: ABVX) and Medtronic (NYSE: MDT)
Needham Analyst forecast on IT:1MDT
Michael Matson
Needham
Needham
€100.57
Buy
27.73%
Upside
Reiterated
09/17/26
Medtronic Reaffirmed at Buy as $700M Cornerstone Robotics Deal Strengthens Surgical Portfolio; Price Target Unchanged at $114
Bank of America Securities Analyst forecast on IT:1MDT
Travis Steed
Bank of America Securities
Bank of America Securities
€97.04
Buy
23.24%
Upside
Reiterated
09/14/26
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (NYSE: ABT), Adagene (NASDAQ: ADAG) and Medtronic (NYSE: MDT)
Citi Analyst forecast on IT:1MDT
Joanne Wuensch
Citi
Citi
€97.04
Buy
23.24%
Upside
Reiterated
09/10/26
Medtronic (MDT) Receives a Buy from Citi
William Blair Analyst forecast on IT:1MDT
Brandon Vazquez
William Blair
William Blair
―
Buy
―
Reiterated
09/10/26
Analyst Brandon Vazquez Reaffirms Buy on Medtronic, Citing Strong FY2027 Outlook and Attractive Risk‑Reward Profile
Wells Fargo Analyst forecast on IT:1MDT
Larry Biegelsen
Wells Fargo
Wells Fargo
€91.75
Buy
16.52%
Upside
Reiterated
09/09/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Deutsche Bank Analyst forecast on IT:1MDT
Pito Chickering
Deutsche Bank
Deutsche Bank
€68.81→€81.16
Hold
3.08%
Upside
Assigned
09/03/26
Medtronic price target raised to $92 from $78 at Deutsche BankMedtronic price target raised to $92 from $78 at Deutsche Bank
J.P. Morgan Analyst forecast on IT:1MDT
Robbie Marcus
J.P. Morgan
J.P. Morgan
€75.87→€84.69
Hold
7.56%
Upside
Reiterated
09/03/26
J.P. Morgan Keeps Their Hold Rating on Medtronic (MDT)
UBS Analyst forecast on IT:1MDT
Patrick Wood
UBS
UBS
€88.22→€97.04
Buy
23.24%
Upside
Assigned
09/03/26
Medtronic price target raised to $110 from $100 at UBSMedtronic price target raised to $110 from $100 at UBS
Raymond James Analyst forecast on IT:1MDT
Jayson Bedford
Raymond James
Raymond James
―
Hold
―
Reiterated
09/02/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Fortrea Holdings Inc. (NASDAQ: FTRE), Medtronic (NYSE: MDT) and Immunic (NASDAQ: IMUX)
Mizuho Securities Analyst forecast on IT:1MDT
Anthony Petrone
Mizuho Securities
Mizuho Securities
€88.22→€101.45
Buy
28.85%
Upside
Reiterated
09/02/26
Medtronic price target raised to $115 from $100 at MizuhoMedtronic price target raised to $115 from $100 at Mizuho
Jefferies Analyst forecast on IT:1MDT
Matthew Taylor
Jefferies
Jefferies
€83.81
Hold
6.44%
Upside
Reiterated
09/02/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: United Therapeutics (NASDAQ: UTHR) and Medtronic (NYSE: MDT)
Truist Financial Analyst forecast on IT:1MDT
Richard Newitter
Truist Financial
Truist Financial
€75.87→€87.34
Hold
10.92%
Upside
Reiterated
09/02/26
Analysts Offer Insights on Healthcare Companies: TransMedics Group (NASDAQ: TMDX), Medtronic (NYSE: MDT) and AbCellera Biologics (NASDAQ: ABCL)
Robert W. Baird Analyst forecast on IT:1MDT
David Rescott
Robert W. Baird
Robert W. Baird
€80.28→€88.22
Hold
12.04%
Upside
Reiterated
09/02/26
Medtronic price target raised to $100 from $91 at BairdMedtronic price target raised to $100 from $91 at Baird
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen Analyst forecast on IT:1MDT
Josh Jennings
TD Cowen
TD Cowen
€97.04
Buy
23.24%
Upside
Reiterated
09/30/26
Analysts Offer Insights on Healthcare Companies: Medtronic (NYSE: MDT) and Conavi Medical (Other OTC: CNVIF)
Piper Sandler Analyst forecast on IT:1MDT
Matthew O'Brien
Piper Sandler
Piper Sandler
€74.99
Hold
-4.77%
Downside
Reiterated
09/28/26
Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (NASDAQ: ABVX) and Medtronic (NYSE: MDT)
Needham Analyst forecast on IT:1MDT
Michael Matson
Needham
Needham
€100.57
Buy
27.73%
Upside
Reiterated
09/17/26
Medtronic Reaffirmed at Buy as $700M Cornerstone Robotics Deal Strengthens Surgical Portfolio; Price Target Unchanged at $114
Bank of America Securities Analyst forecast on IT:1MDT
Travis Steed
Bank of America Securities
Bank of America Securities
€97.04
Buy
23.24%
Upside
Reiterated
09/14/26
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (NYSE: ABT), Adagene (NASDAQ: ADAG) and Medtronic (NYSE: MDT)
Citi Analyst forecast on IT:1MDT
Joanne Wuensch
Citi
Citi
€97.04
Buy
23.24%
Upside
Reiterated
09/10/26
Medtronic (MDT) Receives a Buy from Citi
William Blair Analyst forecast on IT:1MDT
Brandon Vazquez
William Blair
William Blair
―
Buy
―
Reiterated
09/10/26
Analyst Brandon Vazquez Reaffirms Buy on Medtronic, Citing Strong FY2027 Outlook and Attractive Risk‑Reward Profile
Wells Fargo Analyst forecast on IT:1MDT
Larry Biegelsen
Wells Fargo
Wells Fargo
€91.75
Buy
16.52%
Upside
Reiterated
09/09/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Deutsche Bank Analyst forecast on IT:1MDT
Pito Chickering
Deutsche Bank
Deutsche Bank
€68.81→€81.16
Hold
3.08%
Upside
Assigned
09/03/26
Medtronic price target raised to $92 from $78 at Deutsche BankMedtronic price target raised to $92 from $78 at Deutsche Bank
J.P. Morgan Analyst forecast on IT:1MDT
Robbie Marcus
J.P. Morgan
J.P. Morgan
€75.87→€84.69
Hold
7.56%
Upside
Reiterated
09/03/26
J.P. Morgan Keeps Their Hold Rating on Medtronic (MDT)
UBS Analyst forecast on IT:1MDT
Patrick Wood
UBS
UBS
€88.22→€97.04
Buy
23.24%
Upside
Assigned
09/03/26
Medtronic price target raised to $110 from $100 at UBSMedtronic price target raised to $110 from $100 at UBS
Raymond James Analyst forecast on IT:1MDT
Jayson Bedford
Raymond James
Raymond James
―
Hold
―
Reiterated
09/02/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Fortrea Holdings Inc. (NASDAQ: FTRE), Medtronic (NYSE: MDT) and Immunic (NASDAQ: IMUX)
Mizuho Securities Analyst forecast on IT:1MDT
Anthony Petrone
Mizuho Securities
Mizuho Securities
€88.22→€101.45
Buy
28.85%
Upside
Reiterated
09/02/26
Medtronic price target raised to $115 from $100 at MizuhoMedtronic price target raised to $115 from $100 at Mizuho
Jefferies Analyst forecast on IT:1MDT
Matthew Taylor
Jefferies
Jefferies
€83.81
Hold
6.44%
Upside
Reiterated
09/02/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: United Therapeutics (NASDAQ: UTHR) and Medtronic (NYSE: MDT)
Truist Financial Analyst forecast on IT:1MDT
Richard Newitter
Truist Financial
Truist Financial
€75.87→€87.34
Hold
10.92%
Upside
Reiterated
09/02/26
Analysts Offer Insights on Healthcare Companies: TransMedics Group (NASDAQ: TMDX), Medtronic (NYSE: MDT) and AbCellera Biologics (NASDAQ: ABCL)
Robert W. Baird Analyst forecast on IT:1MDT
David Rescott
Robert W. Baird
Robert W. Baird
€80.28→€88.22
Hold
12.04%
Upside
Reiterated
09/02/26
Medtronic price target raised to $100 from $91 at BairdMedtronic price target raised to $100 from $91 at Baird
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
OMCLOmnicell
KNSAKiniksa Pharmaceuticals
ACHVAchieve Life Sciences
AHCOAdaptHealth
ZVRAZevra Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Medtronic

3 Months
Patrick WoodUBS
Success Rate
11/15 ratings generated profit
73%
Average Return
+3.07%
Copying Patrick Wood's trades and holding each position for 3 Months would result in 73.33% of your transactions generating a profit, with an average return of +3.07% per trade.
1 Year
Patrick WoodUBS
Success Rate
12/15 ratings generated profit
80%
Average Return
+6.54%
Copying Patrick Wood's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +6.54% per trade.
2 Years
Larry BiegelsenWells Fargo
Success Rate
28/35 ratings generated profit
80%
Average Return
+9.65%
Copying Larry Biegelsen's trades and holding each position for 2 Years would result in 80.00% of your transactions generating a profit, with an average return of +9.65% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1MDT Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
2
4
4
2
0
Buy
24
30
28
32
34
Hold
12
17
12
12
13
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
38
51
44
46
47
In the current month, 1MDT has received 34 Buy Ratings, 13 Hold Ratings, and 0 Sell Ratings. 1MDT average Analyst price target in the past 3 months is 91.23.
Each month's total comprises the sum of three months' worth of ratings.

1MDT Financial Forecast

1MDT Earnings Forecast

Next quarter’s earnings estimate for 1MDT is €1.18 with a range of €1.16 to €1.23. The previous quarter’s EPS was €1.28. 1MDT beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 1MDT has Performed in-line its overall industry.
Next quarter’s earnings estimate for 1MDT is €1.18 with a range of €1.16 to €1.23. The previous quarter’s EPS was €1.28. 1MDT beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 1MDT has Performed in-line its overall industry.

1MDT Sales Forecast

Next quarter’s sales forecast for 1MDT is €8.37B with a range of €8.33B to €8.41B. The previous quarter’s sales results were €8.61B. 1MDT beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 1MDT has Performed in-line its overall industry.
Next quarter’s sales forecast for 1MDT is €8.37B with a range of €8.33B to €8.41B. The previous quarter’s sales results were €8.61B. 1MDT beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 1MDT has Performed in-line its overall industry.

1MDT Stock Forecast FAQ

What is IT:1MDT’s average 12-month price target, according to analysts?
Based on analyst ratings, Medtronic’s 12-month average price target is 91.23.
    What is IT:1MDT’s upside potential, based on the analysts’ average price target?
    Medtronic has 15.86% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Medtronic a Buy, Sell or Hold?
          Medtronic has a consensus rating of Moderate Buy, which is based on 12 buy ratings, 8 hold ratings and 0 sell ratings.
            What is Medtronic’s share price target?
            The average share price target for Medtronic is 91.23. This is based on 20 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €104.10 ,and the lowest forecast is €74.99. The average share price target represents 15.86% Increase from the current price of €78.74.
              What do analysts say about Medtronic?
              Medtronic’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 20 Wall Streets Analysts.
                How can I buy shares of Medtronic?
                To buy shares of IT:1MDT, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.